FCGR2B and rheumatoid arthritis: Polymorphisms in the FCGR2B promoter or transmembrane domain of FcγRIIB influence receptor expression and signaling potency and are associated with susceptibility to autoimmune diseases including SLE, Goodpasture's disease, ITP, and RA (133–135, 156, 179, 180).